Synthetic Design Lab, a next-generation antibody-drug conjugate (ADC) company advancing its novel SYNTHBODY therapeutic platform against a range of cancer indications, emerged from stealth today with ...

Globally, and especially in low- and middle-income countries (LMICs), a significant portion of the population lacks access to ...